{"id":"W2922069978","doi":"10.1182/blood-2018-99-117571","title":"Canadian Retrospective Multicentric Study Comparing the Combination of Bortezomib, Cyclophosphamide and Dexamethasone (Cybord) Versus Bortezomib, Thalidomide and Dexamethasone (VTD) Versus Bortezomib and Dexamethasone (Vd) in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Hematopoietic Stem Cell Transplantation (HCT)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Thalidomide; Dexamethasone; Internal medicine; Cyclophosphamide; Autologous stem-cell transplantation; Lenalidomide; Oncology; Melphalan; Plasma cell leukemia; Hematopoietic stem cell transplantation; Progression-free survival; Transplantation; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005685938,0.0004051386,0.0007784498,0.000546781,0.001226577,0.0004823152,0.0005061142,0.0005027468,0.002414298],"category_scores_gemma":[0.001058667,0.0003031731,0.0006836897,0.001773901,0.0006343661,0.000221004,0.0003360806,0.0004309435,0.0002118977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006751286,"about_ca_system_score_gemma":0.006298208,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2740434,"about_ca_topic_score_gemma":0.4139864,"domain_scores_codex":[0.9994943,0.00007244707,0.00004939029,0.000139706,0.0001337762,0.0001103033],"domain_scores_gemma":[0.9989962,0.0001264334,0.000302244,0.00003570703,0.0002080586,0.0003313609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01306693,0.00105635,0.9686984,0.000637338,0.0005458399,0.0008024364,0.0004349531,0.0003609605,0.002797208,0.0001140868,0.0009234762,0.01056186],"study_design_scores_gemma":[0.001990145,0.0083604,0.9835916,0.00007358621,0.0004529697,0.001332702,0.0005380759,0.0002369001,0.0005355296,0.00003491858,0.002817681,0.00003539987],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974065,0.000956747,0.00004690026,0.00003295172,0.000007228633,0.0002260924,0.0007993901,0.000002613599,0.0005215147],"genre_scores_gemma":[0.9976707,0.0005696351,0.0002096268,0.0001359796,0.00001888236,0.0001000818,0.001036047,0.000002565564,0.0002564074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7259566,"threshold_uncertainty_score":0.5448965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01675167144090109,"score_gpt":0.2623035745080097,"score_spread":0.2455519030671086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}